Genome-wide association study of germline variants and breast cancer-specific mortality.

Published on Feb 21, 2019in British Journal of Cancer5.791
· DOI :10.1038/S41416-019-0393-X
Maria Escala-Garcia3
Estimated H-index: 3
(NKI-AVL: Netherlands Cancer Institute),
Qi Guo10
Estimated H-index: 10
(University of Cambridge)
+ 233 AuthorsMarjanka K. Schmidt67
Estimated H-index: 67
(NKI-AVL: Netherlands Cancer Institute)
Sources
Abstract
Background: We examined the associations between germline variants and breast cancer mortality using a large meta-analysis of women of European ancestry. Methods: Meta-analyses included summary estimates based on Cox models of twelve datasets using ~10.4 million variants for 96,661 women with breast cancer and 7697 events (breast cancer-specific deaths). Oestrogen receptor (ER)-specific analyses were based on 64,171 ER-positive (4116) and 16,172 ER-negative (2125) patients. We evaluated the probability of a signal to be a true positive using the Bayesian false discovery probability (BFDP). Results: We did not find any variant associated with breast cancer-specific mortality at P < 5 × 10−8. For ER-positive disease, the most significantly associated variant was chr7:rs4717568 (BFDP = 7%, P = 1.28 × 10−7, hazard ratio [HR] = 0.88, 95% confidence interval [CI] = 0.84–0.92); the closest gene is AUTS2. For ER-negative disease, the most significant variant was chr7:rs67918676 (BFDP = 11%, P = 1.38 × 10−7, HR = 1.27, 95% CI = 1.16–1.39); located within a long intergenic non-coding RNA gene (AC004009.3), close to the HOXA gene cluster. Conclusions: We uncovered germline variants on chromosome 7 at BFDP < 15% close to genes for which there is biological evidence related to breast cancer outcome. However, the paucity of variants associated with mortality at genome-wide significance underpins the challenge in providing genetic-based individualised prognostic information for breast cancer patients.
Figures & Tables
Download
📖 Papers frequently viewed together
201742.78Nature
624 Citations
References69
Newest
#1Kyoko Watanabe (VU: VU University Amsterdam)H-Index: 21
#2Erdogan Taskesen (VU: VU University Amsterdam)H-Index: 19
Last. Danielle Posthuma (VU: VU University Amsterdam)H-Index: 101
view all 4 authors...
A main challenge in genome-wide association studies (GWAS) is to pinpoint possible causal variants. Results from GWAS typically do not directly translate into causal variants because the majority of hits are in non-coding or intergenic regions, and the presence of linkage disequilibrium leads to effects being statistically spread out across multiple variants. Post-GWAS annotation facilitates the selection of most likely causal variant(s). Multiple resources are available for post-GWAS annotation...
971 CitationsSource
#1Latha Kadalayil (University of Southampton)H-Index: 11
#2Sofia Khan (UH: University of Helsinki)H-Index: 31
Last. William J. Tapper (Southampton General Hospital)H-Index: 39
view all 16 authors...
To identify genetic variants associated with breast cancer prognosis we conduct a meta-analysis of overall survival (OS) and disease-free survival (DFS) in 6042 patients from four cohorts. In young women, breast cancer is characterized by a higher incidence of adverse pathological features, unique gene expression profiles and worse survival, which may relate to germline variation. To explore this hypothesis, we also perform survival analysis in 2315 patients aged ≤ 40 years at diagnosis. Here, w...
12 CitationsSource
#1Kyriaki Michailidou (University of Cambridge)H-Index: 53
#2Sara Lindström (Harvard University)H-Index: 60
Last. Douglas F. Easton (University of Cambridge)H-Index: 172
view all 359 authors...
Breast cancer risk is influenced by rare coding variants in susceptibility genes, such as BRCA1, and many common, mostly non-coding variants. However, much of the genetic contribution to breast cancer risk remains unknown. Here we report the results of a genome-wide association study of breast cancer in 122,977 cases and 105,974 controls of European ancestry and 14,068 cases and 13,104 controls of East Asian ancestry1. We identified 65 new loci that are associated with overall breast cancer risk...
624 CitationsSource
#2Lead analysts (Swiss Institute of Bioinformatics)H-Index: 2
#4Enhancing GTEx (eGTEx) groups (Stanford University)H-Index: 2
Last. Stephen B. Montgomery (Stanford University)H-Index: 65
view all 11 authors...
Characterization of the molecular function of the human genome and its variation across individuals is essential for identifying the cellular mechanisms that underlie human genetic traits and diseases. The Genotype-Tissue Expression (GTEx) project aims to characterize variation in gene expression levels across individuals and diverse tissues of the human body, many of which are not easily accessible. Here we describe genetic effects on gene expression levels across 44 human tissues. We find that...
2,125 CitationsSource
#1Bingshu Xia (HMU: Harbin Medical University)H-Index: 5
#2Ming Shan (HMU: Harbin Medical University)H-Index: 9
Last. Da Pang (HMU: Harbin Medical University)H-Index: 22
view all 9 authors...
// Bingshu Xia 1 , Ming Shan 1 , Ji Wang 1 , Zhenbin Zhong 1 , Jingshu Geng 2 , Xiaohui He 3 , Tung Vu 4 , Dekai Zhang 4 , Da Pang 1, 5 1 Department of Breast Surgery, Harbin Medical University Cancer Hospital, Harbin, 150081, China 2 Department of Pathology, Harbin Medical University Cancer Hospital, Harbin, 150081, China 3 Department of Medical Records, Harbin Medical University Cancer Hospital, Harbin, 150081, China 4 Center for Infectious and Inflammatory Diseases, Institute of Biosciences a...
13 CitationsSource
#1Patrick Y. P. Kao (PolyU: Hong Kong Polytechnic University)H-Index: 10
#2Kim Hung Leung (PolyU: Hong Kong Polytechnic University)H-Index: 11
Last. Maurice K. H. Yap (PolyU: Hong Kong Polytechnic University)H-Index: 31
view all 5 authors...
Abstract Background Genome-wide association studies (GWAS) is a major method for studying the genetics of complex diseases. Finding all sequence variants to explain fully the aetiology of a disease is difficult because of their small effect sizes. To better explain disease mechanisms, pathway analysis is used to consolidate the effects of multiple variants, and hence increase the power of the study. While pathway analysis has previously been performed within GWAS only, it can now be extended to ...
42 CitationsSource
#1Hoyun Choi (Catholic University of Korea)H-Index: 6
#2Suk Kyeong Lee (Catholic University of Korea)H-Index: 21
MicroRNAs (miRNAs) are a class of noncoding RNA molecules approximately 19 to 25 nucleotides in length that downregulate the expression of target genes at the post-transcriptional level by binding to the 3′-untranslated region (3’-UTR). Epstein-Barr virus (EBV) generates at least 44 miRNAs, but the functions of most of these miRNAs have not yet been identified. Previously, we reported BRUCE as a target of miR-BART15-3p, a miRNA produced by EBV, but our data suggested that there might be other ap...
22 CitationsSource
#1Yinlong Yang (Fudan University)H-Index: 7
#2Jinxian Qian (Fudan University)H-Index: 1
Last. Jinmiao Qu (First Affiliated Hospital of Wenzhou Medical University)H-Index: 2
view all 5 authors...
// Yinlong Yang 1, * , Jinxian Qian 1, * , Youqun Xiang 2 , Yizuo Chen 2 , Jinmiao Qu 2 1 Department of Breast Surgery, Fudan University Shanghai Cancer Center, Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200000, People’s Republic of China 2 Department of Surgical Oncology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou 325000, Zhejiang, People’s Republic of China * These authors have contributed equally to this work Correspondence to: Yinlo...
28 CitationsSource
#1Christopher I. Amos (Dartmouth College)H-Index: 132
#2Joe Dennis (University of Cambridge)H-Index: 55
Last. Douglas F. Easton (University of Cambridge)H-Index: 172
view all 93 authors...
Background:Common cancers develop through a multistep process often including inherited susceptibility. Collaboration among multiple institutions, and funding from multiple sources, has allowed the development of an inexpensive genotyping microarray, the OncoArray. The array includes a genome-wide backbone, comprising 230,000 SNPs tagging most common genetic variants, together with dense mapping of known susceptibility regions, rare variants from sequencing experiments, pharmacogenetic markers a...
187 CitationsSource
#1Alexandra J. van den Broek (NKI-AVL: Netherlands Cancer Institute)H-Index: 11
#2Laura J. van't Veer (NKI-AVL: Netherlands Cancer Institute)H-Index: 90
Last. Marjanka K. Schmidt (NKI-AVL: Netherlands Cancer Institute)H-Index: 67
view all 17 authors...
PurposeTo determine prospectively overall and age-specific estimates of contralateral breast cancer (CBC) risk for young patients with breast cancer with or without BRCA1/2 mutations.Patients and MethodsA cohort of 6,294 patients with invasive breast cancer diagnosed under 50 years of age and treated between 1970 and 2003 in 10 Dutch centers was tested for the most prevalent BRCA1/2 mutations. We report absolute risks and hazard ratios within the cohort from competing risk analyses.ResultsAfter ...
59 CitationsSource
Cited By18
Newest
#1Anna Morra (NKI-AVL: Netherlands Cancer Institute)H-Index: 1
#2Maria Escala-Garcia (NKI-AVL: Netherlands Cancer Institute)H-Index: 3
Last. Paul L. Auer (UWM: University of Wisconsin–Milwaukee)H-Index: 48
view all 0 authors...
BACKGROUND Given the high heterogeneity among breast tumors, associations between common germline genetic variants and survival that may exist within specific subgroups could go undetected in an unstratified set of breast cancer patients. METHODS We performed genome-wide association analyses within 15 subgroups of breast cancer patients based on prognostic factors, including hormone receptors, tumor grade, age, and type of systemic treatment. Analyses were based on 91,686 female patients of Euro...
Source
#1Erika Korobeinikova (Lithuanian University of Health Sciences)H-Index: 2
#2Rasa Ugenskiene (Lithuanian University of Health Sciences)H-Index: 3
Last. Elona Juozaityte (Lithuanian University of Health Sciences)H-Index: 10
view all 6 authors...
BACKGROUND Genetic variations in oxidative stress-related genes may alter the coded protein level and impact the pathogenesis of breast cancer. METHODS The current study investigated the associations of functional single nucleotide polymorphisms in the NFE2L2, HMOX1, P21, TXNRD2, and ATF3 genes with the early-stage breast cancer clinicopathological characteristics and disease-free survival, metastasis-free survival, and overall survival. A total of 202 Eastern European (Lithuanian) women with pr...
Source
#1Manuel Gentiluomo (UniPi: University of Pisa)H-Index: 6
#2C. Corradi (UniPi: University of Pisa)H-Index: 1
Last. Gabriele Capurso (UniSR: Vita-Salute San Raffaele University)H-Index: 56
view all 31 authors...
Although pancreatic ductal adenocarcinoma (PDAC) survival is poor, there are differences in patients' response to the treatments. Detection of predictive biomarkers explaining these differences is of the utmost importance. In a recent study two genetic markers (CD44-rs353630 and CHI3L2-rs684559) were reported to be associated with survival after PDAC resection. We attempted to replicate the associations in 1856 PDAC patients (685 resected with stage I/II) from the PANcreatic Disease ReseArch (PA...
Source
#1Duna Barakeh (KSU: King Saud University)H-Index: 2
#2Rasha Aljelaify (KACST: King Abdulaziz City for Science and Technology)H-Index: 4
Last. Malak Abedalthagafi (KACST: King Abdulaziz City for Science and Technology)H-Index: 22
view all 11 authors...
Breast cancer (BCa) ranks first in incidence rate among cancers in Arab females. The association between genetic polymorphisms in tumor suppressor genes and the risk of BCa has been studied in many ethnic populations with conflicting conclusions while Arab females and Saudi Arabian studies are still lacking. We screened a cohort of Saudi BCa patients by NGS using a bespoke gene panel to clarify the genetic landscape of this population, correlating and assessing genetic findings with clinical out...
1 CitationsSource
#1Achal P. Patel (UNC: University of North Carolina at Chapel Hill)H-Index: 1
#1Achal P. Patel (UNC: University of North Carolina at Chapel Hill)H-Index: 2
view all 7 authors...
BackgroundContinuous risk of recurrence scores (CRS) based on PAM50 gene expression are vital prognostic tools for breast cancer (BC). Studies have shown that Black women (BW) have higher CRS than White women (WW). Although systemic injustices contribute substantially to BC disparities, evidence for biological and germline contributions is emerging. We investigated germline genetic associations with CRS and CRS disparity through a Transcriptome-Wide Association Study (TWAS). MethodsIn the Caroli...
1 CitationsSource
#1Juliette Coignard (French Institute of Health and Medical Research)H-Index: 1
#1Juliette CoignardH-Index: 1
Last. Antonis C. Antoniou (University of Cambridge)H-Index: 83
view all 3 authors...
Breast cancer (BC) risk for BRCA1 and BRCA2 mutation carriers varies by genetic and familial factors. About 50 common variants have been shown to modify BC risk for mutation carriers. All but three, were identified in general population studies. Other mutation carrier-specific susceptibility variants may exist but studies of mutation carriers have so far been underpowered. We conduct a novel case-only genome-wide association study comparing genotype frequencies between 60,212 general population ...
Source
#1Guohua RongH-Index: 2
#2Zongbi YiH-Index: 8
Last. Binghe XuH-Index: 31
view all 7 authors...
Background High tumor heterogeneity contributes to breast cancer recurrence and metastasis. However, the lack of indicators to serve as precise and reliable means of predicting breast cancer prognosis has yet to be addressed. This study aims to reveal the prognostic relevance of mutations in metastatic breast cancer (MBC) by large-scale circulating tumor DNA (ctDNA) analysis in China. Methods We performed ctDNA panel-captured sequencing of 958 blood samples from MBC patients including 494 hormon...
Source
#1Peng Chan Lin (NCKU: National Cheng Kung University)H-Index: 13
#2Hui-O Chen (NCKU: National Cheng Kung University)
Last. Jung-Hsien Chiang (NCKU: National Cheng Kung University)H-Index: 26
view all 6 authors...
BACKGROUND Functional disruptions by large germline genomic structural variants in susceptible genes are known risks for cancer. We used deletion structural variants (DSVs) generated from germline whole-genome sequencing (WGS) and DSV immune-related association tumor microenvironment (TME) to predict cancer risk and prognosis. METHODS We investigated the contribution of germline DSVs to cancer susceptibility and prognosis by silicon and causal inference models. DSVs in germline WGS data were gen...
Source
#1Ernest Mangantig (Universiti Sains Malaysia)H-Index: 3
#2Stuart MacGregor (QIMR: QIMR Berghofer Medical Research Institute)H-Index: 85
Last. Matthew Law (QIMR: QIMR Berghofer Medical Research Institute)H-Index: 97
view all 20 authors...
Germline genetic variants have been identified, which predispose individuals and families to develop melanoma. Tumor thickness is the strongest predictor of outcome for clinically localized primary melanoma patients. We sought to determine whether there is a heritable genetic contribution to variation in tumor thickness. If confirmed, this will justify the search for specific genetic variants influencing tumor thickness. To address this, we estimated the proportion of variation in tumor thicknes...
Source
#1Maria Escala-Garcia (NKI-AVL: Netherlands Cancer Institute)H-Index: 3
#2Anna Morra (NKI-AVL: Netherlands Cancer Institute)H-Index: 1
Last. Marjanka K. Schmidt (NKI-AVL: Netherlands Cancer Institute)H-Index: 67
view all 10 authors...
Observational studies have investigated the association of risk factors with breast cancer prognosis. However, the results have been conflicting and it has been challenging to establish causality due to potential residual confounding. Using a Mendelian randomisation (MR) approach, we aimed to examine the potential causal association between breast cancer-specific survival and nine established risk factors for breast cancer: alcohol consumption, body mass index, height, physical activity, mammogr...
3 CitationsSource